1 EXHIBIT 10.1 Portions of Exhibit 10.1 have been redacted and are the subject of a confidential treatment request filed with the Secretary of the Securities and Exchange Commission. LICENSE AGREEMENT AGREEMENT made this 3rd day of January, 2000 (the...License Agreement • June 19th, 2000 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
